SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in SELLAS Life Sciences Group, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +2 vs. Q3 2022
- Shares held
- 1.89M
- +10.7K (+0.6%) vs. Q3 2022
- Total value
- $4.46M
- +$661.3K (+17.4%) vs. Q3 2022
- New holders
- 9
- 9 more added
- Sold out
- 7
- 5 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $1.08B |
| Q1 2026 | 160 | $228.4M |
| Q4 2025 | 112 | $133.7M |
| Q3 2025 | 94 | $53.1M |
| Q2 2025 | 79 | $58.7M |
| Q1 2025 | 45 | $15.5M |
| Q4 2024 | 31 | $6.47M |
| Q3 2024 | 33 | $6.77M |
| Q2 2024 | 30 | $4.86M |
| Q1 2024 | 30 | $7.82M |
| Q4 2023 | 31 | $3.74M |
| Q3 2023 | 28 | $4.54M |
| Q2 2023 | 25 | $4.91M |
| Q1 2023 | 22 | $4.28M |
| Q4 2022 | 29 | $4.46M |
| Q3 2022 | 28 | $4.42M |
| Q2 2022 | 26 | $6.64M |
| Q1 2022 | 26 | $11.3M |
| Q4 2021 | 27 | $10.1M |
| Q3 2021 | 30 | $17.1M |
| Q2 2021 | 29 | $21.3M |
| Q1 2021 | 31 | $13.3M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding SELLAS Life Sciences Group, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 856,084 | $2.02M | 0.00% | +25,965+3.1% | Added |
| BlackRock Inc. | 259,905 | $613.4K | 0.00% | +3,645+1.4% | Added |
| Geode Capital Management, LLC | 188,066 | $443.0K | 0.00% | +43,347+30.0% | Added |
| Equitable Holdings, Inc. | 113,000 | $266.7K | 0.00% | +3,000+2.7% | Added |
| State Street Corp | 71,729 | $169.3K | 0.00% | +13,523+23.2% | Added |
| Millennium Management LLC | 61,179 | $144.0K | 0.00% | +36,396+146.9% | Added |
| Dimensional Fund Advisors LP | 58,592 | $138.0K | 0.00% | +58,592 | New |
| Morgan Stanley | 55,558 | $131.1K | 0.00% | +2,133+4.0% | Added |
| XTX Topco Ltd | 55,403 | $130.8K | 0.03% | +55,403 | New |
| Northern Trust Corp | 37,671 | $88.9K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 20,832 | $49.2K | 0.00% | +585+2.9% | Added |
| Opus Capital Group, LLC | 19,672 | $46.0K | 0.01% | +19,672 | New |
| Virtu Financial LLC | 18,379 | $43.0K | 0.01% | +18,379 | New |
| Price T Rowe Associates Inc | 17,100 | $40.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 16,238 | $38.3K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 16,140 | $38.1K | 0.00% | +5,004+44.9% | Added |
| Two Sigma Securities, LLC | 16,076 | $37.9K | 0.01% | +16,076 | New |
| Citadel Advisors LLC | 3,375 | $7.96K | 0.00% | −104,185−96.9% | Reduced |
| Advisor Group Holdings, Inc. | 1,660 | $4.00K | 0.00% | −5−0.3% | Reduced |
| Tower Research Capital LLC (TRC) | 1,206 | $3.00K | 0.00% | −1,475−55.0% | Reduced |
| Global Retirement Partners, LLC | 1,000 | $2.36K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 150 | $354 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 100 | $236 | 0.00% | +100 | New |
| NewSquare Capital LLC | 100 | $236 | 0.00% | +100 | New |
| Bank of America Corp | 48 | $114 | 0.00% | +48 | New |
| Godsey & Gibb Associates | 4 | $9 | 0.00% | +4 | New |
| Parkside Financial Bank & Trust | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 300 | $0 | 0.00% | −1,200−80.0% | Reduced |
| Royal Bank of Canada | 200 | $0 | 0.00% | −126−38.7% | Reduced |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −53,685−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −22,400−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,550−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,359−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,315−100.0% | Sold out |
| Empery Asset Management, LP | – | – | – | – | Not filed |